3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
2
Heart Diseases
1
Cardiotoxicity
1
Interventions
Antineoplastic Agents
3
Nutrition Assessment
2
Echocardiography
2
Blood Specimen Collection
2
liposomal doxorubicin
1
Vitamin E
1
Vital Signs
1
Tomography, X-Ray Computed
1
Tomography, Emission-Computed
1
Therapeutics
1
Surveys and Questionnaires
1
Specimen Handling
1
Positron-Emission Tomography
1
Methods
1
Mass Screening
1
Magnetic Resonance Imaging
1
Interviews as Topic
1
Immunomodulating Agents
1
Immune Checkpoint Inhibitors
1
Hematologic Tests
1
Exercise Test
1
Chemoradiotherapy
1
Case Management
1
Breathing Exercises
1
Atorvastatin
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Heart Diseases
×
Immunomodulating Agents
×
Clear all
NCT03530215
2023-04-13
EROCA
Groupe Hospitalier Pitie-Salpetriere
Completed
500,000 enrolled